can teladoc prescribe semaglutide Employers grapple with reining in costs for GLP-1s: CEO Oral GLP-1s change the form—not

Moreover, in a 2025 systematic review 2 by Raheem et al

We uncover topics around weight loss, side effects of different GLP-1 RAs, and concerns about drug access and supply, with a mainly neutral-to-positive view of GLP-1 RAs, highlighting the role of an AI-enabled pipeline to help monitor for emerging side effects, uncover public sentiment, and guide future directions for research and public health efforts

Better physician education can help clinicians respond consistently to patient questions, while accessible patient-facing resources can counter misinformation before it reaches the exam room

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways